ISSN: 2324-8637

Journal Home

Journal Guideline

Human gene therapy. Clinical development Q3 Unclaimed

Mary Ann Liebert Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Human gene therapy. Clinical development is a journal indexed in SJR in Genetics (clinical) with an H index of 31. It has a price of 2395 €. It has an SJR impact factor of 0,61 and it has a best quartile of Q3. It has an SJR impact factor of 0,61.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Genetics (clinical) (Q3)

Price

2395 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Human gene therapy. Clinical development

0,61

SJR Impact factor

31

H Index

0

Total Docs (Last Year)

25

Total Docs (3 years)

0

Total Refs

47

Total Cites (3 years)

19

Citable Docs (3 years)

0

Cites/Doc (2 years)

0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Molecular genetics & genomic medicine Q3
Annals of Human Genetics Q3
BMC Medical Genetics Q3
Clinical Respiratory Journal Q3
Current Genomics Q3

Compare this journals

Aims and Scope

Best articles by citations

Pulsed Versus Continuous Application of the Prodrug 5-Fluorocytosine to Enhance the Oncolytic Effectiveness of a Measles Vaccine Virus Armed with a Suicide Gene

A Multicenter, Single-Blind, Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of a Cell-Mediated Gene Therapy in Degenerative Knee Arthritis Patients

Safety and Efficacy of AAV5 Vectors Expressing Human or Canine CNGB3 in CNGB3-Mutant Dogs

A Journey in the Development of Gene Therapy for Inherited Disorders of the Bone Marrow

Not Reinventing the Wheel: Applying the 3Rs Concepts to Viral Vector Gene Therapy Biodistribution Studies

Dog Models for Blinding Inherited Retinal Degenerations

Safety of Direct Cardiac Administration of AdVEGF-All6A+, a Replication Deficient Adenovirus Vector cDNA/Genomic Hybrid Expressing All Three Major Isoforms of Human Vascular Endothelial Growth Factor, to the Ischemic Myocardium of Rats

Safety of Direct Cardiac Administration of AdVEGF-All6A+, a Replication-Deficient Adenovirus Vector cDNA/Genomic Hybrid Expressing All Three Major Isoforms of Human Vascular Endothelial Growth Factor, to the Ischemic Myocardium of Rats

A review of gene therapy in canine and feline models of lysosomal storage disorders

Standing on the Shoulders of Stem Cell Gene Therapists: History, Hyperbole, and Hope for the Future

Nonclinical Pharmacology/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia

Improvement of Adeno-Associated Virus-Mediated Liver Transduction Efficacy by Regional Administration in Macaca fascicularis

SHOW MORE ARTICLES

Herpes Simplex Virus Clearance during Purification of a Recombinant Adeno-associated Virus Serotype 1 Vector

A Corticosteroid Gene Therapy Combination Strategy to Maximize Intramuscular-Mediated Delivery in Postischemic Myocardium

Clinical Development and Commercialization of Advanced Therapy Medicinal Products in the European Union: How Are the Product Pipeline and Regulatory Framework Evolving?

Introduction: Gene and Cell Therapy Projects of the Seventh Framework Program

Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy

Varinostat Alters Gene Expression Profiles in Aortic Tissues from ApoE-/-Mice

Feasibility and Safety of Systemic rAAV9-hNAGLU Delivery for Treating Mucopolysaccharidosis IIIB: Toxicology, Biodistribution, and Immunological Assessments in Primates

Sequenom, the U.S. Supreme Court, and Personalized Medicine

Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide

Ferret and Pig Models of Cystic Fibrosis: Prospects and Promise for Gene Therapy

Adenovirus-Mediated FKHRL1/TM Sensitizes Melanoma Cells to Apoptosis Induced by Temozolomide

Influence of Mildly Acidic pH Conditions on the Production of Lentiviral and Retroviral Vectors